The images for S1 Fig To assess whether degradation of fibrinogen occurs during prolonged incubation at 37°C, purified fibrinogen was incubated for 24 h (Fg (24 h)). Furthermore, fibrinogen (20 μg/ml) was incubated with the activator uPA (0.16 μg/ml) either in the absence (Fg-Plg +uPA) or in the presence of 10 μg/ml plasminogen (Fg +Plg +uPA), in a total volume of 100 μl 50 mM Tris/HCl pH 7.5. Reactions were incubated for 2 h at 37°C. Following incubation, samples were separated via SDS-PAGE and blotted onto nitrocellulose. The membrane was probed with an antiserum raised against fibriniogen (1:1000) to visualize fibrinoigen or its degradation products. Purified fibrinogen (500 ng) served as an additional control. To determine the stability of C3b over prolonged incubation at 37°C, purified C3b was incubated for 24 h (C3b (24h)). Degradation of C3b by factor I in the presence of factor H was also assessed. C3b (20 μg/ml) was incubated with factor H (10 μg/ml, FH) and factor I (5 μg/ml, FI) in a total volume of 100 μl 50 mM Tris/HCl pH 7.5 for 2 h at 37°C. Additionally, C3b (20 μg/ml) was incubated with uPA (0.16 μg/ml) either in the absence (C3b -Plg +uPA) or in the presence of 10 μg/ml plasminogen (C3b +Plg +uPA) in a total volume of 100 μl 50 mM Tris/HCl pH 7.5 for 2 h at 37°C. Samples were separated by SDS-PAGE and transferred to a nitrocellulose membrane. C3b and its degradation products were detected by a polyclonal antiserum raised against C3. Purified C3b (500 ng) served as an additional control. 
